Fourrts India

EU/MHRA Approved Facility

  • State-of-the-art facility with a built-up area of 19230 Sq.mts.
  • 100% Export Oriented Unit
  • EU/MHRA Approved Site
  • Also approved for supplies to Australia, Canada and Ethiopia
  • Manufacturing Tablets and Capsules
  • Capacity 3 billion tablets, 350 million capsules
  • 3 Granulation, 5 Compression, 4 Coating and 7 Packaging lines.
  • Doing contract manufacturing for UK and Australian customer
  • This site is approved by Mylan and Aurobindo.
  • Triggering for USFDA by 2022